Additionally, Zhu et al. also reported that there is a potential role of histone 3/4 acetylation in modulating access to the polymorphic sites within intron 2 in addition to downstream splicing sites in generating variable FGFR2 levels and isoforms in breast cancer [43]. This evidence concerns the gene FGFR2 and breast cancer.